Previously approved for IV infusion.
Reduces risk for heart failure and cardiovascular disease hospitalizations.
As people with type 2 diabetes age, the risks of insulin use can outweigh its benefits, creating the need for increased provider and patient education.
Tips for identifying patients with diabetes who need more direction and help.
Noteworthy diabetes management products and updates making waves this year.
New CGM eliminates fingersticks, introduces new data presentation.
Now approved for risk reductions in patients with type 2 diabetes mellitus.
Cost, education, self-monitoring, and more.
FDA approved the first and only ready-to-use insulin for IV infusion in hospitals and acute care settings.
How pipeline promises—and disappointments—are impacting patients with diabetes.